Matches in Wikidata for { <http://www.wikidata.org/entity/Q64642141> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q64642141 description "clinical trial" @default.
- Q64642141 description "ensayu clínicu" @default.
- Q64642141 description "klinisch onderzoek" @default.
- Q64642141 description "клінічне випробування" @default.
- Q64642141 name "OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone" @default.
- Q64642141 type Item @default.
- Q64642141 label "OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone" @default.
- Q64642141 prefLabel "OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone" @default.
- Q64642141 P1132 Q64642141-30C2F02C-487D-45F7-9ACC-795F578DE738 @default.
- Q64642141 P1476 Q64642141-B024F966-B219-4A01-9F84-61DAF0796A61 @default.
- Q64642141 P17 Q64642141-4524C193-4B17-4B5A-BE86-339F5FDE5C39 @default.
- Q64642141 P17 Q64642141-8FA9A5F4-DEB4-4FEC-9047-9730820BC037 @default.
- Q64642141 P2899 Q64642141-DEAC933E-AEBE-44CB-9DEB-03890EA54D3A @default.
- Q64642141 P3098 Q64642141-6ABC223B-63CA-4AC4-917E-3DFA421C27A1 @default.
- Q64642141 P31 Q64642141-2AF4F569-2288-41ED-AEE7-35B241FA5AB8 @default.
- Q64642141 P4844 Q64642141-8CAB6CAA-4F46-4D8F-8603-7EA323AF735D @default.
- Q64642141 P580 Q64642141-9FE0F038-B61C-47CE-9108-446A737A6214 @default.
- Q64642141 P582 Q64642141-4F7A7334-819A-4B9F-B4C3-DAE1A6AA2B2C @default.
- Q64642141 P6099 Q64642141-9213CEE5-9732-4DCE-A563-1AF55635946C @default.
- Q64642141 P6153 Q64642141-1F1E1A85-8C75-423E-AF01-929E9F17A04B @default.
- Q64642141 P6153 Q64642141-5C053F06-48CF-4603-BEAE-18CDDE795949 @default.
- Q64642141 P6153 Q64642141-86A1B397-60FF-4E00-B7CC-D79FDD70D559 @default.
- Q64642141 P6153 Q64642141-A3FBE8C9-C176-4B52-9103-70BBB4AD2B4A @default.
- Q64642141 P6153 Q64642141-CD38C039-9C87-4B6D-AFCD-5A6221B86473 @default.
- Q64642141 P6153 Q64642141-ED4E869C-104A-4D4F-943F-E5BC0A89E7DE @default.
- Q64642141 P8363 Q64642141-B8911809-6105-423D-9B02-D92557FE7A84 @default.
- Q64642141 P1132 "+72" @default.
- Q64642141 P1476 "The Pacific Clinical Trial: A Randomized Phase II Study Evaluating OGX-427 in Patients With Metastatic Castrate-Resistant Prostate Cancer (MCRPC)Who Have Prostate-Specific Antigen (PSA) Progression While Receiving Abiraterone: Hoosier Oncology Group GU12-159" @default.
- Q64642141 P17 Q16 @default.
- Q64642141 P17 Q30 @default.
- Q64642141 P2899 "+18" @default.
- Q64642141 P3098 "NCT01681433" @default.
- Q64642141 P31 Q30612 @default.
- Q64642141 P4844 Q424972 @default.
- Q64642141 P580 "2012-12-01T00:00:00Z" @default.
- Q64642141 P582 "2017-06-21T00:00:00Z" @default.
- Q64642141 P6099 Q42824440 @default.
- Q64642141 P6153 Q1130172 @default.
- Q64642141 P6153 Q1159198 @default.
- Q64642141 P6153 Q1433199 @default.
- Q64642141 P6153 Q30270654 @default.
- Q64642141 P6153 Q4835275 @default.
- Q64642141 P6153 Q5188247 @default.
- Q64642141 P8363 Q78089383 @default.